News

NeuroOne Medical Technologies Corporation (NMTC) Q2 2025 Earnings Call Transcript
Welcome to the Second Quarter of Fiscal Year 2025 Financial Results Conference Call for NeuroOne Medical Technologies Corporation. Today's call will be conducted by the company's Chief Executive ...
NeuroOne expects FY25 revenue to reach $8M–$10M as OneRF platform advances and new FDA submission broadens pipeline
Discover Q2 2025 insights for NeuroOne (NMTC), including 97% revenue growth, FDA submissions, and strategic partnerships fueling innovation and expansion.
The Manila Times3h
NeuroOne® Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6%
"The second quarter of fiscal 2025 was highlighted by our significant operational progress with our commercial OneRF ® Ablation System technology platform, which is increasingly being validated as a ...